Latest pharma updates on API Sourcing
Why Your API Costs Just Went Up (And What You Can Actually Do About It)
By Mitul Agarwal, CEO/ Founder at Pharmatradz.com With over 25+ years connecting pharmaceutical companies w...
Read Full Story
Pharma Tender Sourcing Strategy: How Distributors & Hospitals Choose the Right Manufacturer
Introduction Pharma tenders have evolved; they’re not just about the lowest price anymore. Hospitals, governmen...
Read Full Story
API Price Trends 2026: Cost Drivers, China Dependency & Alternatives for Buyers
Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...
Read Full Story
Pharmaceutical Sourcing for Latin America: A Buyer's Guide to Medicines, APIs and CDMOs (2026)
By the PharmaTradz BD Team. Updated October 2026. Latin America is not one market. A buyer working across the region dea...
Read Full Story
Global API Sourcing 2026: Best Regions, Cost Benchmarks & Supplier Validation Checklist
Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...
Read Full Story
B2B Pharma Market Review 2025 & 2026 Outlook: Sourcing, Manufacturing, Regulation & Trade Trends
Executive Summary For the global B2B pharmaceutical ecosystem, the year 2025 is seen as critical for both COVID-relat...
Read Full Story
Authenticity & Risk Management in Global Pharma Sourcing (2026)
The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...
Read Full Story
Generic API Suppliers in India and China: How to Compare and Qualify Them (2026)
Most of the world's generic APIs are made in India and China. If you buy APIs on cost, you will almost certainly end up...
Read Full Story
Latin America Pharmaceutical Market: A Comprehensive Guide for Global Pharma Buyers
Introduction The Latin American pharmaceutical market is an ever-increasing sector that keeps on drawing global inves...
Read Full Story